Abstract Background Epstein‐Barr Virus (EBV) is strongly associated with multiple sclerosis
(MS). After initial infection, EBV maintains a life‐long latent infection in B lymphocytes …

In a recent study published in Cell, Vietzen and colleagues discovered the novel role of
natural killer (NK) cells and EBV-specific CD8+ T cell response in controlling EBV-inducing …

The role of CD8+ T cells in multiple sclerosis (MS) and experimental autoimmune
encephalomyelitis (EAE) is still unclear. We describe here significantly reduced disease …

Background Epstein-Barr virus (EBV) is a likely prerequisite for multiple sclerosis (MS) but
the underlying mechanisms are unknown. We investigated antibody and T cell responses to …

B cells are increasingly regarded as integral to the pathogenesis of multiple sclerosis, in part
as a result of the success of B cell–depletion therapy. Multiple B cell–dependent …

Editorial Kakalacheva & Comabella found to be significantly elevated in patients with CIS
compared with patients with relapsing-remitting and progressive forms of MS and healthy …

EBV infection has long been suspected to play a role in the development of autoimmune
diseases. Interestingly, a recently published study has provided the strongest evidence to …

Symptomatic primary Epstein-Barr virus (EBV) infection and elevated humoral immune
responses to EBV are associated with an increased risk of developing multiple sclerosis …

Objective Clinical studies indicate that anti‐CD20 B‐cell depletion may be an effective
multiple sclerosis (MS) therapy. We investigated mechanisms of anti‐CD20‐mediated …

The Epstein-Barr virus (EBV) has been implicated in the pathogenesis of multiple sclerosis
(MS), however, the mechanisms by which EBV may be involved in MS are unknown. We …